United States· US:54973-4092_340ac69e-0018-804d-e063-6294a90ae8fe
Kali Phos 6X
A medicinal product containing potassium phosphate, dibasic, registered in United States by Hyland's Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- POTASSIUM PHOSPHATE, DIBASIC
- Manufacturer
- Hyland's Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1154973409211 BOTTLE, PLASTIC in 1 CARTON (54973-4092-1) / 100 TABLET, SOLUBLE in 1 BOTTLE, PLASTIC
- ndc1154973-4092-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Potassium phosphate, dibasic in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandK-FosfosterilOrion Corporation Orion Pharma
- FrancePHOSPHATE DIPOTASSIQUE RENAUDIN 174,20 mg/ml, solution pour perfusionLABORATOIRE RENAUDIN
- Japanリン酸二カリウムテルモ
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Spain · Fosfato Dipotasico 1m Fresenius Kabi
- France · Phosphate Dipotassique Renaudin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9d60995-7d13-4911-b4d9-b3d83f5c69c9 GET /v1/drugs/f9d60995-7d13-4911-b4d9-b3d83f5c69c9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "6",
"substance": "POTASSIUM PHOSPHATE, DIBASIC",
"productndc": "54973-4092",
"dosage_form": "TABLET, SOLUBLE",
"dea_schedule": null,
"strength_unit": "[hp_X]/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about potassium phosphate, dibasic.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.